Seattle-based Jintronix has announced that it received 510(k) clearance from the FDA for its rehabilitation software. Jintronix's system is a set of games and exercises designed for Microsoft's Xbox Kinect system to stimulate recovery in stroke victims. The Kinect's motion-sensing camera allows players to interact with what they see on the screen, providing immediate feedback for patients.
Jintronix sells the Kinect for $250 and charges $50 a month for its software, which lets physical therapists track patient progress, program routines for patients, and adjust the exercises as mobility improves.
According to the company, the FDA clearance is the first time that the Microsoft Kinect has been approved for use directly by patients in a healthcare setting.
Jintronix sells the Kinect for $250 and charges $50 a month for its software, which lets physical therapists track patient progress, program routines for patients, and adjust the exercises as mobility improves.
According to the company, the FDA clearance is the first time that the Microsoft Kinect has been approved for use directly by patients in a healthcare setting.
RSS Feed
